Literature DB >> 2850348

Antiserotonergic inhibition of calcitonin-induced increase of beta-endorphin, ACTH, and cortisol secretion.

L Laurian1, Z Oberman, E Hoerer, E Graf.   

Abstract

In a previous study we observed that calcitonin increases beta-endorphin, ACTH, and cortisol secretion. We assumed that calcitonin might have a modulatory role on the pituitary function. The present study was initiated to clarify whether this effect is due to a direct pituitary stimulation or to an indirect stimulation through CRF (corticotropin releasing factor). Fourteen healthy subjects, aged 30-60 years were investigated. All the subjects received 100 IU Salmon calcitonin Sandoz i.v. at 8 a.m. (time 0). Plasma beta-endorphin, ACTH and cortisol were estimated every 30 min from -30 to 120 min by specific radioimmunoassay. The same parameters were estimated a second time, at the same intervals, when cyproheptadine 8 mg (7 subjects) and 40 mg propranolol (7 subjects) were given per os at -30 min and calcitonin i.v. at time 0. beta-endorphin, ACTH and cortisol levels (Mean +/- SEM) rose significantly after calcitonin (peak value at 30-90 min) from 5.2 +/- 0.7 to 15.1 +/- 2.6 pmol/l; from 43.0 +/- 2.7 to 70.7 +/- 4.1 pg/ml and from 10.6 +/- 1.5 to 19.6 +/- 2.1 micrograms/100 ml respectively (p less than 0.0001 by analysis of variance and covariance and repeated measures). Propranolol 40 mg (per os) administered at time -30 did not alter the response of beta-endorphin, ACTH and cortisol to calcitonin (infused at time 0). Cyproheptadine, the antiserotonergic substance that inhibits the synthesis and release of CRF completely inhibited the stimulatory effect of calcitonin. We conclude that probably calcitonin has a modulatory role on the hypothalamo-pituitary adrenal axis and that it acts at the hypothalamic level probably by stimulating CRF secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850348     DOI: 10.1007/bf01250134

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  34 in total

1.  Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; M Nakamura; A C Chang; S N Cohen; S Numa
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

2.  Hypothalamic polypeptides and analogues on corticotrophin production by rat adenohypophysial tissue in vitro [proceedings].

Authors:  J C Buckingham; J R Hodges
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

3.  Examination of interspecies differences in renal and skeletal receptor binding and adenylate cyclase stimulation with human calcitonin.

Authors:  D Goltzman
Journal:  Endocrinology       Date:  1980-02       Impact factor: 4.736

4.  Elevated serum calcitonin and serum calcium during suckling in the baby rat.

Authors:  C W Cooper; J F Obie; S U Toverud; P L Munson
Journal:  Endocrinology       Date:  1977-12       Impact factor: 4.736

5.  The effect of cyproheptadine on the release of corticotrophin releasing factor.

Authors:  M T Jones; M Birmingham; B Gillham; M Holmes; T Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1979-02       Impact factor: 3.478

6.  Simultaneous determination of human plasma immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin using immuno-affinity chromatography.

Authors:  H Yamaguchi; A S Liotta; D T Krieger
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

7.  Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans.

Authors:  F Petraglia; F Facchinetti; E Martignoni; G Nappi; A Volpe; A R Genazzani
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

8.  The analgesic effect of calcitonin in humans: studies on the role of opioid peptides.

Authors:  A Fabbri; C Santoro; C Moretti; M Cappa; F Fraioli; G P Di Julio; T Galluzzi; V La Manna
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-11

9.  Plasma adrenocorticotropin, cortisol, and aldosterone responses to corticotropin-releasing factor: modulatory effect of basal cortisol levels.

Authors:  A R Hermus; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

10.  Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland.

Authors:  S W Lamberts; E G Bons; P Uitterlinden; W H Hackeng
Journal:  J Endocrinol       Date:  1983-03       Impact factor: 4.286

View more
  2 in total

1.  The effect of calcitonin on beta-endorphin levels in postmenopausal osteoporotic patients with back pain.

Authors:  D Ofluoglu; G Akyuz; O Unay; O Kayhan
Journal:  Clin Rheumatol       Date:  2006-03-31       Impact factor: 2.980

2.  Dexamethasone suppression of the calcitonin induced beta-endorphin, ACTH and cortisol secretion.

Authors:  Z Oberman; E Graff; R Chayen; N Grazas; A Burstein; L Laurian
Journal:  J Neural Transm Gen Sect       Date:  1992
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.